[
  {
    "ts": null,
    "headline": "Why Eli Lilly (LLY) is Emerging as a Dividend Growth Leader in Pharma for 2025",
    "summary": "Eli Lilly and Company (NYSE:LLY) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. In the past five years, the company has raised its payouts at an annual average rate of 16%. Its consistent track record makes it an appealing choice for investors focused on dividend growth, especially given the strength […]",
    "url": "https://finnhub.io/api/news?id=5226b5d8146ec5e5da67dd31d4314cd3bdbfd84b782e9bbcf6ecbe72ff2a7012",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752889793,
      "headline": "Why Eli Lilly (LLY) is Emerging as a Dividend Growth Leader in Pharma for 2025",
      "id": 136011760,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly and Company (NYSE:LLY) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. In the past five years, the company has raised its payouts at an annual average rate of 16%. Its consistent track record makes it an appealing choice for investors focused on dividend growth, especially given the strength […]",
      "url": "https://finnhub.io/api/news?id=5226b5d8146ec5e5da67dd31d4314cd3bdbfd84b782e9bbcf6ecbe72ff2a7012"
    }
  }
]